The gravity of these decisions calls for a degree of humility on the part of an FDA leader. And that’s the rub with Vinay ...

Lisa Jarvis The controversial appointment of oncologist Vinay Prasad — an outspoken critic of the pharmaceutical industry and U.S. health agencies — to a key role within the Food and Drug ...

For a brief period in 2022, Dr. Vinay Prasad faked a concern about routine vaccines to infect unvaccinated children with ...

A new cadre of officials might deal in evidence more than Robert F. Kennedy Jr. does, but they still question the worth of ...

A hot (if cautious) topic at the big gene therapy meeting: what Vinay Prasad's appointment might mean for approvals in rare ...

At the American Society of Cell and Gene Therapy conference, there were questions and qualms on how Vinay Prasad may change ...

Vinay Prasad may have just started as the new director of the FDA's biologics center, but he's 'planning to unleash a massive ...

FDA to release new guidance soon, clarifying its regulatory framework related to vaccines, particularly COVID-19 shots. Read ...

Jay Bhattacharya, Marty Makary, and Vinay Prasad challenged the public health orthodoxy in our pages. Now, they have the power to fix things. Will they pull it off?

President Donald Trump unwrapped a massive drug pricing policy as CMS prepares for the next round of Medicare drug price ...